The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for children ...

Zydus Pinkathon marks grand return to Delhi for eighth edition on March 8, 2026: Our Bureau, Mumbai Wednesday, January 14, ...

ZYCUBO is a subcutaneous injectable formulation of copper histidinate designed to restore copper homeostasis and maintain adequate copper levels in patients with Menkes disease.

New evidence shows physical activity, especially walking, can significantly improve survival in breast cancer patients, even those genetically prone to obesity, highlighting fitness, early detection, ...

Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.

Zydus Wellness Products Limited (ZWPL), a wholly owned subsidiary of Zydus Wellness Limited, has received ad-interim relief ...

New Delhi: Supermodel and actor Milind Soman, who is widely known for promoting an active lifestyle and age-defying fitness, said true fitness goes beyond physical strength and praised megastar ...

The US Food and Drug Administration yesterday approved the Zycubo (copper histidinate) injection as the first treatment for Menkes disease in pediatric patients. The FDA approved Zycubo, previously ...

The Indian pharmaceutical and life sciences sector entered FY26 after a reform-oriented Union Budget 2025 that focused on tax ...

Milind Soman said Amitabh Bachchan has seen extreme highs and lows, yet managed to remain disciplined, which proves that age ...

US rare disease specialist Sentynl Therapeutics, owned by India’s Zydus Lifesciences (NSE: ZYDUSLIFE), says the US regulator ...

India's pharmaceutical sector continues to remain an attractive space for investors, supported by strong domestic demand, ...